tiprankstipranks
Advertisement

CWS - ETF AI Analysis

Compare

Top Page

CWS

AdvisorShares Focused Equity ETF (CWS)

Rating:74Outperform
Price Target:
CWS (AdvisorShares Focused Equity ETF) earns a solid overall rating, mainly because it holds several financially strong companies like Comfort Systems USA, Amphenol, and Mueller Industries, which show robust growth, profitability, and positive earnings trends. These high-quality, growth-focused holdings help lift the fund’s quality, while weaker names such as McKesson, with leverage and bearish technical signals, and Casey’s General Stores, with overvaluation and bearish trends, slightly weigh on the rating. The main risk is that many top holdings share similar growth and premium-valuation profiles, so if market sentiment turns against higher-priced, momentum-driven stocks, the ETF could be more volatile.
Positive Factors
Strong Top Holdings
Most of the fund’s largest positions have shown strong gains this year, helping support overall performance.
Sector Diversification
The ETF spreads its investments across several sectors, including health care, industrials, technology, and consumer companies, which helps reduce reliance on any single industry.
Focused U.S. Exposure
With nearly all assets in U.S. companies, the fund offers targeted exposure to the U.S. market for investors who want to emphasize domestic stocks.
Negative Factors
High Expense Ratio
The fund’s management fee is relatively high for an ETF, which can eat into long-term returns compared with lower-cost options.
Concentrated Top Holdings
A meaningful share of assets is tied up in a small number of stocks, increasing the impact that any one company’s weakness can have on the fund.
Limited International Diversification
Because the ETF invests almost entirely in U.S. companies, investors get little protection from growth or diversification opportunities in other regions.

CWS vs. SPDR S&P 500 ETF (SPY)

CWS Summary

AdvisorShares Focused Equity ETF (CWS) is an actively managed fund that doesn’t track a set index, but instead picks a focused group of U.S. stocks across many sectors like health care, industrials, and technology. It aims to balance growth and stability by investing in companies such as McKesson and Amphenol, giving investors a diversified mix of different sizes and styles of businesses. Someone might consider CWS if they want a single fund that spreads money across many industries while still being carefully selected by managers. A key risk is that its stock picks can rise or fall more than the overall market, and there is no index as a guide.
How much will it cost me?The AdvisorShares Focused Equity ETF (CWS) has an expense ratio of 0.72%, which means you’ll pay $7.20 per year for every $1,000 invested. This is higher than average because it is actively managed, meaning professional managers select stocks rather than tracking an index. Active management often comes with higher costs due to research and decision-making efforts.
What would affect this ETF?The AdvisorShares Focused Equity ETF (CWS), with strong exposure to technology, industrials, and healthcare sectors, could benefit from innovation-driven growth, infrastructure spending, and advancements in medical technology. However, it may face challenges from rising interest rates, which can impact growth stocks, and economic slowdowns that could affect consumer cyclical and industrial sectors. Its U.S.-focused portfolio is also sensitive to domestic regulatory changes and broader economic conditions.

CWS Top 10 Holdings

CWS is leaning heavily into U.S. health care and industrial names, and that’s where most of the action is. Comfort Systems and IES Holdings have been big engines for the fund over the year, though Comfort Systems has recently lost some steam. On the steadier side, Allison Transmission and SAIC are quietly pulling their weight with rising share prices. In health care, Thermo Fisher and McKesson are climbing again, helping offset lagging moves from Casey’s General Stores, which has turned from earlier strength to a recent drag.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Comfort Systems6.66%$8.70M$56.67B124.95%
80
Outperform
IES Holdings6.27%$8.19M$12.85B78.77%
76
Outperform
Casey's General5.22%$6.81M$27.98B39.68%
68
Neutral
Allison Transmission Holdings5.09%$6.64M$10.84B45.85%
71
Outperform
Science Applications4.79%$6.26M$5.31B23.54%
71
Outperform
Amphenol4.70%$6.14M$204.13B49.77%
78
Outperform
Henry Schein4.56%$5.95M$10.01B32.58%
74
Outperform
McKesson4.28%$5.59M$105.86B30.27%
62
Neutral
Mueller Industries4.20%$5.48M$14.10B31.03%
78
Outperform
American Water4.13%$5.39M$27.96B0.44%
73
Outperform

CWS Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
70.81
Negative
100DMA
69.29
Negative
200DMA
68.77
Negative
Market Momentum
MACD
-0.42
Positive
RSI
29.03
Positive
STOCH
0.88
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CWS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 72.08, equal to the 50-day MA of 70.81, and equal to the 200-day MA of 68.77, indicating a bearish trend. The MACD of -0.42 indicates Positive momentum. The RSI at 29.03 is Positive, neither overbought nor oversold. The STOCH value of 0.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CWS.

CWS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$126.13M0.65%
74
Outperform
$999.45M0.18%
71
Outperform
$806.99M0.45%
74
Outperform
$799.23M0.22%
61
Neutral
$743.06M1.30%
65
Neutral
$730.45M0.71%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CWS
AdvisorShares Focused Equity ETF
68.34
-0.73
-1.06%
VFMF
Vanguard U.S. Multifactor ETF
BGDV
Bahl & Gaynor Dividend ETF
AVTM
Avantis Total Equity Markets ETF
ULTY
YieldMax Ultra Option Income Strategy ETF
SMRI
Bushido Capital US Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement